Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | BNT152 |
| Synonyms | |
| Therapy Description |
BNT152 consists of a modified mRNA for IL-7 contained within a lipid nanoparticle, which leads to expression of IL-7 and activation of downstream signaling, potentially resulting in increased antitumor immune response (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| BNT152 | BNT-152|BNT 152 | BNT152 consists of a modified mRNA for IL-7 contained within a lipid nanoparticle, which leads to expression of IL-7 and activation of downstream signaling, potentially resulting in increased antitumor immune response (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT04710043 | Phase I | BNT152 BNT153 | Dose Escalation Trial of BNT152+153 in Patients With Cancer | Completed | USA | CZE | 0 |